Abstract

Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2018 - Volume 22, Number 1

Page(s): 55

Download in electronic PDF format for $75
  • Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension Page 1

Abstract

A formulation for preparing Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • penicillamine-D
  • chelating agent
  • heavy metals
  • rheumatoid arthritis
  • cystinuria
  • primary biliary cirrhosis
  • scleroderma
  • Wilson disease
  • copper poisoning
  • lead poisoning

Related Categories

  • EXCIPIENTS
  • FORMULATIONS
  • GASTROENTEROLOGY
  • ALLERGY/IMMUNOLOGY/INFLAMMATION

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2018
Pg. 55
Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2016
Pg. 167-174
Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions
Author(s): Polonini HC, Loures S, Lima LC, Ferreira AO, Brandão MA
Jul/Aug 2003
Pg. 272-275
Effectiveness in Oral Rhus toxicodendron Solution for Poison Ivy Prevention
Author(s): Stein Michael F, Parsons Eric
Nov/Dec 2019
Pg. 493
Ursodiol 30 mg/mL in SyrSpend SF Cherry Oral Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2020
Pg. 407
Levofloxacin 50 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 412
Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2021
Pg. 46
Diclofenac Sodium 5 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Mar/Apr 2022
Pg. 140
Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2019
Pg. 490
Sulfasalazine 100 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Mar/Apr 2022
Pg. 149
Pyridoxine Hydrochloride 50 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Jan/Feb 2021
Pg. 42
Acetaminophen (Paracetamol) 50 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Nov/Dec 2021
Pg. 503
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2017
Pg. 491
Dapsone 2 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2020
Pg. 60
Ondansetron Hydrochloride 0.8 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2020
Pg. 38-43
Basics: Excipients Used in Nonsterile Compounding, Part 4: Antioxidants and Chelating Agents
Author(s): Allen Loyd V Jr
Nov/Dec 2019
Pg. 486
Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2018
Pg. 494
Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr